Cancer Control & Population Sciences
Cancer Therapeutics & Host Response
Cancer Control & Population Sciences
Mkuu RS, Staras SA, Szurek SM, D’Ingeo D, Gerend MA, Goede DL, Shenkman EA. Clinicians’ perceptions of barriers to cervical cancer screening for women living with behavioral health conditions: a focus group study. BMC Cancer. 2022 Mar 9;22(1):252. doi: 10.1186/s12885-022-09350-5. PubMed PMID: 35264120; PubMed Central PMCID: PMC8905024.
Xie Z, Chen G, Suk R, Dixon B, Jo A, Hong YR. Limited English Proficiency and Screening for Cervical, Breast, and Colorectal Cancers among Asian American Adults. J Racial Ethn Health Disparities. 2022 Mar 16. doi: 10.1007/s40615-022-01285-8. [Epub ahead of print] PubMed PMID: 35297497.
Luo C, Islam MN, Sheils NE, Buresh J, Reps J, Schuemie MJ, Ryan PB, Edmondson M, Duan R, Tong J, Marks-Anglin A, Bian J, Chen Z, Duarte-Salles T, Fernández-BertolÃn S, Falconer T, Kim C, Park RW, Pfohl SR, Shah NH, Williams AE, Xu H, Zhou Y, Lautenbach E, Doshi JA, Werner RM, Asch DA, Chen Y. DLMM as a lossless one-shot algorithm for collaborative multi-site distributed linear mixed models. Nat Commun. 2022 Mar 30;13(1):1678. doi: 10.1038/s41467-022-29160-4. PubMed PMID: 35354802.
Alishahi Tabriz A, Turner K, Clary A, Hong YR, Nguyen OT, Wei G, Carlson RB, Birken SA. De-implementing low-value care in cancer care delivery: a systematic review. Implement Sci. 2022 Mar 12;17(1):24. doi: 10.1186/s13012-022-01197-5. PubMed PMID: 35279182; PubMed Central PMCID: PMC8917720.
Yang Y, Lindblom EN, Ward KD, Salloum RG. How Smokers of Menthol Cigarettes and Flavored Cigars Might Respond to FDA’s Proposed Bans. Nicotine Tob Res. 2022 Mar 30. pii: ntac078. doi: 10.1093/ntr/ntac078. [Epub ahead of print] PubMed PMID: 35353183.
Rutenberg MS, Holtzman AL, Indelicato DJ, Huh S, Rao D, Fiester PJ, Morris CG, Tavanaiepour D, Amdur RJ. Disease Control after Radiotherapy for Adult Craniopharyngioma: Clinical Outcomes from a Large Single-Institution Series. J Neurooncol. 2022 Mar 12. doi: 10.1007/s11060-022-03983-z. [Epub ahead of print] PubMed PMID: 35278157.
Christy SM, Sutton SK, Abdulla R, Boxtha C, Gonzalez P, Cousin L, Ewing A, Montoya S, Lopez D, Beehler T, Sanchez J, Carvajal R, Meade CD, Gwede CK. A multilevel, low literacy dual language intervention to promote colorectal cancer screening in community clinics in Florida: A randomized controlled trial. Prev Med. 2022 Mar 16:107021. doi: 10.1016/j.ypmed.2022.107021. [Epub ahead of print] PubMed PMID: 35305995.
Nakkash R, Khader Y, Chalak A, Abla R, Abu-Rmeileh NME, Mostafa A, Jawad M, Lee JH, Salloum RG. Prevalence of cigarette and waterpipe tobacco smoking among adults in three Eastern Mediterranean countries: a cross-sectional household survey. BMJ Open. 2022 Mar 4;12(3):e055201. doi: 10.1136/bmjopen-2021-055201. PubMed PMID: 35246419; PubMed Central PMCID: PMC8900030.
LeLaurin JH, Thrasher JF, Strayer SM, Malaty J, Kollath-Cattano C, Williams M, Nguyen OT, Kellner AM, Smith JM, Salloum RG. Feasibility of a primary care patient decision aid for smoking cessation with information about e-cigarettes. Prev Med Rep. 2022 Mar 1;26:101745. doi: 10.1016/j.pmedr.2022.101745. eCollection 2022 Apr. PubMed PMID: 35251914; PubMed Central PMCID: PMC8892147.
Oladeru OT, Ma SJ, Miccio JA, Wang K, Attwood K, Singh AK, Haas-Kogan DA, Neira PM. Breast and Cervical Cancer Screening Disparities in Transgender People. Am J Clin Oncol. 2022 Mar 1;45(3):116-121. doi: 10.1097/COC.0000000000000893. PubMed PMID: 35195561.
Kendzor DE, Businelle MS, Vidrine DJ, Frank-Pearce SG, Shih YT, Dallery J, Alexander AC, Boozary LK, Waring JJC, Ehlke SJ. Mobile contingency management for smoking cessation among socioeconomically disadvantaged adults: Protocol for a randomized trial. Contemp Clin Trials. 2022 Mar;114:106701. doi: 10.1016/j.cct.2022.106701. Epub 2022 Jan 31. PubMed PMID: 35114409.
Lyon D. We Thank You: Now Let’s Work Together to Enact Change. Oncol Nurs Forum. 2022 Mar 1;49(2):101-102. doi: 10.1188/22.ONF.101-102. PubMed PMID: 35191903.
Neil JM, Parker ND, Levites Strekalova YA, Duke K, George T, Krieger JL. Communicating risk to promote colorectal cancer screening: a multi-method study to test tailored versus targeted message strategies. Health Educ Res. 2022 Mar 24;37(2):79-93. doi: 10.1093/her/cyac002. PubMed PMID: 35234890.
Hanna K, Arredondo BL, Chavez MN, Geiss C, Hume E, Szalacha L, Christy SM, Vadaparampil S, Menon U, Islam J, Hong YR, Alishahi Tabriz A, Kue J, Turner K. Cancer Screening Among Rural and Urban Clinics During COVID-19: A Multistate Qualitative Study. JCO Oncol Pract. 2022 Mar 7:OP2100658. doi: 10.1200/OP.21.00658. [Epub ahead of print] PubMed PMID: 35254884.
Pang SS, Murphy M, Markham MJ. Current Management of Locally Advanced and Metastatic Cervical Cancer in the United States. JCO Oncol Pract. 2022 Mar 14:OP2100795. doi: 10.1200/OP.21.00795. [Epub ahead of print] PubMed PMID: 35286157.
Chidharla A, Utengen A, Attai DJ, Drake EK, van Londen GJ, Subbiah IM, Henry E, Murphy M, Barry MM, Manochakian R, Moerdler S, Loeb S, Graff SL, Leyfman Y, Thompson MA, Markham MJ. Social Media and Professional Development for Oncology Professionals. JCO Oncol Pract. 2022 Mar 21:OP2100761. doi: 10.1200/OP.21.00761. [Epub ahead of print] PubMed PMID: 35312343.
Cancer Therapeutics & Host Response
Ali A, Shah AA, Jeang LJ, Fallgatter KS, George TJ, DeRemer DL. Emergence of ocular toxicities associated with novel anticancer therapeutics: What the oncologist needs to know. Cancer Treat Rev. 2022 Mar 12;105:102376. doi: 10.1016/j.ctrv.2022.102376. [Epub ahead of print] Review. PubMed PMID: 35303547.
Newsome RC, Gharaibeh RZ, Pierce CM, da Silva WV, Paul S, Hogue SR, Yu Q, Antonia S, Conejo-Garcia JR, Robinson LA, Jobin C. Interaction of bacterial genera associated with therapeutic response to immune checkpoint PD-1 blockade in a United States cohort. Genome Med. 2022 Mar 29;14(1):35. doi: 10.1186/s13073-022-01037-7. PubMed PMID: 35346337; PubMed Central PMCID: PMC8961902.
Riner AN, Girma S, Vudatha V, Mukhopadhyay N, Skoro N, Gal TS, Freudenberger DC, Herremans KM, George TJ, Trevino JG. Eligibility Criteria Perpetuate Disparities in Enrollment and Participation of Black Patients in Pancreatic Cancer Clinical Trials. J Clin Oncol. 2022 Mar 22:JCO2102492. doi: 10.1200/JCO.21.02492. [Epub ahead of print] PubMed PMID: 35316089.
Newsome R, Jobin C. Finding clues in unexpected places: detection of pancreatic cancer through the faecal microbiome. Gut. 2022 Mar 8. pii: gutjnl-2021-326710. doi: 10.1136/gutjnl-2021-326710. [Epub ahead of print] PubMed PMID: 35260443.
Dean JW, Zhou L. Cell-intrinsic view of the aryl hydrocarbon receptor in tumor immunity. Trends Immunol. 2022 Mar;43(3):245-258. doi: 10.1016/j.it.2022.01.008. Epub 2022 Feb 5. Review. PubMed PMID: 35131180; PubMed Central PMCID: PMC8882133.
Hoppe BS, Nichols RC, Flampouri S, Pankuch M, Morris CG, Pham DC, Mohindra P, Hartsell WF, Mohammed N, Chon BH, Kestin LL, Simone CB. Chemoradiation with Hypofractionated Proton Therapy in Stage II-III Non-Small Cell Lung Cancer: A YYY Phase 1/2 Trial. Int J Radiat Oncol Biol Phys. 2022 Mar 16. pii: S0360-3016(22)00238-3. doi: 10.1016/j.ijrobp.2022.03.005. [Epub ahead of print] PubMed PMID: 35306151.
Nguyen DT, Famiglietti JE, Smolchek RA, Dupee Z, Diodati N, Pedro DI, Urueña JM, Schaller MA, Sawyer WG. 3D In Vitro Platform for Cell and Explant Culture in Liquid-like Solids. Cells. 2022 Mar 11;11(6). pii: 967. doi: 10.3390/cells11060967. PubMed PMID: 35326418.
Markovic M, Ben-Shabat S, Nagendra Manda J, Abramov-Harpaz K, Regev C, Miller Y, Aponick A, Zimmermann EM, Dahan A. PLA(2)-Triggered Activation of Cyclosporine-Phospholipid Prodrug as a Drug Targeting Approach in Inflammatory Bowel Disease Therapy. Pharmaceutics. 2022 Mar 18;14(3). pii: 675. doi: 10.3390/pharmaceutics14030675. PubMed PMID: 35336048.
Karalis JD, Yoon LY, Hammer STG, Hong C, Zhu M, Nassour I, Ju MR, Xiao S, Castro-Dubon EC, Agrawal D, Suarez J, Reznik SI, Mansour JC, Polanco PM, Yopp AC, Zeh HJ 3rd, Hwang TH, Zhu H, Porembka MR, Wang SC. Lenvatinib inhibits the growth of gastric cancer patient-derived xenografts generated from a heterogeneous population. J Transl Med. 2022 Mar 7;20(1):116. doi: 10.1186/s12967-022-03317-7. PubMed PMID: 35255940; PubMed Central PMCID: PMC8900296.
Bian T, Ding H, Wang Y, Hu Q, Chen S, Fujioka N, Aly FZ, Lu J, Huo Z, Xing C. Suppressing the activation of protein kinase A as a DNA damage-independent mechanistic lead for dihydromethysticin (DHM) prophylaxis of NNK-induced lung carcinogenesis. Carcinogenesis. 2022 Mar 30. pii: bgac031. doi: 10.1093/carcin/bgac031. [Epub ahead of print] PubMed PMID: 35353881.
Salem ME, El-Refai SM, Sha W, Puccini A, Grothey A, George TJ, Hwang JJ, O’Neil B, Barrett AS, Kadakia KC, Musselwhite LW, Raghavan D, Van Cutsem E, Tabernero J, Tie J. Landscape of KRAS(G12C), Associated Genomic Alterations, and Interrelation With Immuno-Oncology Biomarkers in KRAS-Mutated Cancers. JCO Precis Oncol. 2022 Mar;6:e2100245. doi: 10.1200/PO.21.00245. PubMed PMID: 35319967.
Iqbal A, Aijaz N, Hughes SJ, Tan SA, Read TE. The Impact of a Narcotic-Sparing Enhanced Recovery Protocol on Postoperative Narcotic Use following Colectomy. Dis Colon Rectum. 2022 Mar 22. doi: 10.1097/DCR.0000000000002292. [Epub ahead of print] PubMed PMID: 35316244.
Gunasekera SP, Kokkaliari S, Ratnayake R, Sauvage T, Dos Santos LAH, Luesch H, Paul VJ. Anti-Inflammatory Dysidazirine Carboxylic Acid from the Marine Cyanobacterium Caldora sp. Collected from the Reefs of Fort Lauderdale, Florida. Molecules. 2022 Mar 6;27(5). pii: 1717. doi: 10.3390/molecules27051717. PubMed PMID: 35268819; PubMed Central PMCID: PMC8911782.
Gupta S, Li D, Ostrov DA, Nguyen CQ. Epitope Mapping of Pathogenic Autoantigens on Sjögren’s Syndrome-Susceptible Human Leukocyte Antigens Using In Silico Techniques. J Clin Med. 2022 Mar 18;11(6). pii: 1690. doi: 10.3390/jcm11061690. PubMed PMID: 35330015.
Atanasova KR, Chakraborty S, Ratnayake R, Khare KD, Luesch H, Lele TP. An epigenetic small molecule screen to target abnormal nuclear morphology in human cells. Mol Biol Cell. 2022 Mar 24:mbcE21100528. doi: 10.1091/mbc.E21-10-0528. [Epub ahead of print] PubMed PMID: 35323046.
Rutenberg MS, Holtzman AL, Indelicato DJ, Huh S, Rao D, Fiester PJ, Morris CG, Tavanaiepour D, Amdur RJ. Disease Control after Radiotherapy for Adult Craniopharyngioma: Clinical Outcomes from a Large Single-Institution Series. J Neurooncol. 2022 Mar 12. doi: 10.1007/s11060-022-03983-z. [Epub ahead of print] PubMed PMID: 35278157.
Das IJ, Dawes SL, Dominello MM, Kavanagh B, Miyamoto CT, Pawlicki T, Santanam L, Vinogradskiy Y, Yeung AR. Quality and Safety Considerations in Stereotactic Radiosurgery and Stereotactic Body Radiation Therapy: An ASTRO Safety White Paper Update. Pract Radiat Oncol. 2022 Mar 9. pii: S1879-8500(22)00075-3. doi: 10.1016/j.prro.2022.03.001. [Epub ahead of print] PubMed PMID: 35283342.
Nassour I, AlMasri S, Hodges JC, Hughes SJ, Zureikat A, Paniccia A. Novel Calculator to Estimate the Risk of Clinically Relevant Postoperative Pancreatic Fistula Following Distal Pancreatectomy. J Gastrointest Surg. 2022 Mar 29. doi: 10.1007/s11605-022-05275-3. [Epub ahead of print] PubMed PMID: 35352209.
Efron PA, Darden DB, Li EC, Munley J, Kelly L, Fenner B, Nacionales DC, Ungaro RF, Dirain ML, Rincon J, Mankowski RT, Leeuwenburgh C, Moore FA, Brakenridge SC, Foster TC, Laitano O, Casadesus G, Moldawer LL, Mohr AM, Thomas RM. SEX DIFFERENCES ASSOCIATE WITH LATE MICROBIOME ALTERATIONS AFTER MURINE SURGICAL SEPSIS. J Trauma Acute Care Surg. 2022 Mar 24. doi: 10.1097/TA.0000000000003599. [Epub ahead of print] PubMed PMID: 35324554.
Walker AL, Marchi E, Puig A, Slayton W, Dodd V, McVay MA, Livingston MD. Volunteer-Based Social Support Structures and Program Exposure Outcomes in an Adolescent Young Adult Palliative Care Peer Support Program. J Palliat Med. 2022 Mar 23. doi: 10.1089/jpm.2021.0426. [Epub ahead of print] PubMed PMID: 35333622.
Bertran J, Thomson ACS. Current Concepts in Head and Neck Surgery. Vet Clin North Am Small Anim Pract. 2022 Mar;52(2):489-512. doi: 10.1016/j.cvsm.2021.12.006. Review. PubMed PMID: 35210061.
Engelien JL, Lejeune AT, Dark MJ, Milner RJ, Shiomitsu K. RNA in situ hybridisation as a molecular diagnostic technique targeting IBA-1 and CD204 in canine histiocytic sarcoma. Vet Med Sci. 2022 Mar 26. doi: 10.1002/vms3.795. [Epub ahead of print] PubMed PMID: 35339118.
Neil JM, Parker ND, Levites Strekalova YA, Duke K, George T, Krieger JL. Communicating risk to promote colorectal cancer screening: a multi-method study to test tailored versus targeted message strategies. Health Educ Res. 2022 Mar 24;37(2):79-93. doi: 10.1093/her/cyac002. PubMed PMID: 35234890.
Pang SS, Murphy M, Markham MJ. Current Management of Locally Advanced and Metastatic Cervical Cancer in the United States. JCO Oncol Pract. 2022 Mar 14:OP2100795. doi: 10.1200/OP.21.00795. [Epub ahead of print] PubMed PMID: 35286157.
Chidharla A, Utengen A, Attai DJ, Drake EK, van Londen GJ, Subbiah IM, Henry E, Murphy M, Barry MM, Manochakian R, Moerdler S, Loeb S, Graff SL, Leyfman Y, Thompson MA, Markham MJ. Social Media and Professional Development for Oncology Professionals. JCO Oncol Pract. 2022 Mar 21:OP2100761. doi: 10.1200/OP.21.00761. [Epub ahead of print] PubMed PMID: 35312343.
Yergin CG, Chang M, Thomas RM. When is a lipoma not a lipoma? Case report presenting a lipoblastoma-like tumor of the gluteal cleft in an older gentleman with literature review. Int J Surg Case Rep. 2022 Mar;92:106889. doi: 10.1016/j.ijscr.2022.106889. Epub 2022 Mar 1. PubMed PMID: 35245849; PubMed Central PMCID: PMC8892077.
Bloom MD, Saker H, Glisch C, Ramnaraign B, George TJ, Markham MJ, Kelkar AH. Administration of Immune Checkpoint Inhibitors Near the End of Life. JCO Oncol Pract. 2022 Mar 7:OP2100689. doi: 10.1200/OP.21.00689. [Epub ahead of print] PubMed PMID: 35254868.
Mechanisms of Oncogenesis
de Andrade KC, Lee EE, Tookmanian EM, Kesserwan CA, Manfredi JJ, Hatton JN, Loukissas JK, Zavadil J, Zhou L, Olivier M, Frone MN, Shahzada O, Longabaugh WJR, Kratz CP, Malkin D, Hainaut P, Savage SA. The TP53 Database: transition from the International Agency for Research on Cancer to the US National Cancer Institute. Cell Death Differ. 2022 Mar 29. doi: 10.1038/s41418-022-00976-3. [Epub ahead of print] PubMed PMID: 35352025.
Sriramareddy SN, Faião-Flores F, Emmons MF, Saha B, Chellappan S, Wyatt C, Smalley I, Licht JD, Durante MA, Harbour JW, Smalley KSM. HDAC11 activity contributes to MEK inhibitor escape in uveal melanoma. Cancer Gene Ther. 2022 Mar 24. doi: 10.1038/s41417-022-00452-7. [Epub ahead of print] PubMed PMID: 35332245.
Sangoi AR, Maclean F, Mohanty S, Hes O, Daniel R, Lal P, Canete-Portillo S, Magi-Galluzzi C, Cornejo KM, Collins K, Hwang M, Falzarano SM, Feely MM, Dababneh M, Harik L, Tretiakova M, Akgul M, Manucha V, Chan E, Kao CS, Siadat F, Arora K, Barkan G, Cheng L, Hirsch M, Lei L, Wasco M, Williamson SR, Acosta AM. Granulomas associated with renal neoplasms: A multi-institutional clinicopathological study of 111 cases. Histopathology. 2022 Mar 29. doi: 10.1111/his.14633. [Epub ahead of print] PubMed PMID: 35347739.
Shabashvili DE, Feng Y, Kaur P, Venugopal K, Guryanova OA. Combination strategies to promote sensitivity to cytarabine-induced replication stress in acute myeloid leukemia with and without DNMT3A mutations. Exp Hematol. 2022 Mar 16. pii: S0301-472X(22)00125-4. doi: 10.1016/j.exphem.2022.03.008. [Epub ahead of print] Review. PubMed PMID: 35306047.
Gao S, Martcheva M, Miao H, Rong L. A two-sex model of human papillomavirus infection: Vaccination strategies and a case study. J Theor Biol. 2022 Mar 7;536:111006. doi: 10.1016/j.jtbi.2022.111006. Epub 2022 Jan 8. PubMed PMID: 35007512.